Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.2079
-0.0041 (-1.93%)
At close: Oct 16, 2026, 4:00 PM
0.2290
+0.0211 (10.15%)
After-hours: Oct 16, 2026, 7:58 PM EDT
Theriva Biologics Market Cap
Theriva Biologics has a market cap or net worth of $9.54 million as of October 16, 2026. It is the 41,875th most valuable company in the world and the 5,641st biggest in the United States. Its market cap has increased by 17.79% in one year.
Market Cap
9.54M
Enterprise Value
1.76M
1-Year Change
17.79%
Global Rank
Country Rank
#5,641 United States
Category
ChartMarket Cap Chart
Since April 2, 2007, Theriva Biologics's market cap has decreased from $81.60M to $9.54M, a decrease of -88.31%. That is a compound annual growth rate of -10.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 9.50M | 33.80% |
| Dec 31, 2025 | 7.10M | 44.90% |
| Dec 31, 2024 | 4.90M | -32.88% |
| Dec 29, 2023 | 7.30M | 1.39% |
| Dec 30, 2022 | 7.20M | -79.94% |
| Dec 31, 2021 | 35.90M | 366.23% |
| Dec 31, 2020 | 7.70M | -9.41% |
| Dec 31, 2019 | 8.50M | 11.84% |
| Dec 31, 2018 | 7.60M | -88.36% |
| Dec 29, 2017 | 65.30M | -7.11% |
| Dec 30, 2016 | 70.30M | -66.19% |
| Dec 31, 2015 | 207.90M | 96.32% |
| Dec 31, 2014 | 105.90M | 55.05% |
| Dec 31, 2013 | 68.30M | -11.18% |
| Dec 31, 2012 | 76.90M | 116.62% |
| Dec 30, 2011 | 35.50M | 22.84% |
| Dec 31, 2010 | 28.90M | 140.83% |
| Dec 31, 2009 | 12.00M | 224.32% |
| Dec 31, 2008 | 3.70M | -96.22% |
| Dec 31, 2007 | 97.80M | 19.85% |
| Apr 2, 2007 | 81.60M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 10.54M |
| CytoMed Therapeutics | 10.50M |
| Tempest Therapeutics | 10.32M |
| Phio Pharmaceuticals | 10.12M |
| Ensysce Biosciences | 10.08M |
| Lisata Therapeutics | 9.28M |
| Chemomab Therapeutics | 9.17M |
| Adial Pharmaceuticals | 9.16M |